e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of hypersensitivity pneumonitis (HP) - targeting pathways of inflammation and fibrosis
T. Maher (St. Albans, Hertfordshire, United Kingdom)
Source:
International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management
Session:
Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management
Session type:
Lunchtime session
Number:
4321
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Maher (St. Albans, Hertfordshire, United Kingdom). Treatment of hypersensitivity pneumonitis (HP) - targeting pathways of inflammation and fibrosis. International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
HISTOLOGICAL FINDINGS IN TRANSBRONCHIAL CRYOBIOPSIES OBTAINED FROM PATIENTS AFTER COVID-19
Does “UIPAF” really exist?
Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Related content which might interest you:
Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006
Pathogenisis of hypersensitivity pneumonitis (HP) - current concepts
Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management
Year: 2017
Chronic hypersensitivity pneumonitis and its differential diagnosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189
Year: 2007
Pathology of hypersensitivity pneumonitis (HP)
Source: International Congress 2017 – Hypersensitivity pneumonitis: current concepts and perspectives in diagnosis, pathogenesis and management
Year: 2017
Alveolar epithelium in sarcoidosis (S) and hypersensitivity pneumonitis (HP)
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Difference in immunological aspects of inflammation in idiopathic pulmonary fibrosis (IPF) and exogenous toxic alveolitis (ETA)
Source: Eur Respir J 2003; 22: Suppl. 45, 121s
Year: 2003
Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Small airways impairment and air-trapping distinguish chronic hypersensitivity pneumonitis (CHP) from idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Mechanisms of treatment response to pirfenidone of idiopathic pulmonary fibrosis (IPF) patients
Source: International Congress 2016 – IPF pathogenesis
Year: 2016
Treatment response in hypersensitivity pneumonitis
Source: International Congress 2016 – Orphan diseases II
Year: 2016
High mobility group box protein 1 (HMGB1) production in highly vascularized alveolar lesions causes acute exacerbation in idiopathic pulmonary fibrosis
Source: Annual Congress 2005 - Progresses in lung fibrosis
Year: 2005
Consort hypersensitivity pneumonitis
Source: Eur Respir J 2009; 33: 1223-1225
Year: 2009
Monocyte inflammatory responsiveness and potential therapeutic target for pigeon fancier‘s hypersensitivity pneumonitis (HP)
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012
Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Source: Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019
Year: 2019
Procoagulant and antifibrynolitic activities strongly correlate with fibrosis and tissue turn-over markers in patients with active idiopathic pulmonary fibrosis and hypersensitivity pneumonitis
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Distinguishing fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Source: International Congress 2019 – Lungs in the fog
Year: 2019
The role of pulmonary structural cells in pulmonary fibrosis in a model of hypersensitivity pneumonitis
Source: Annual Congress 2010 - Immune modulation of airways diseases
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept